Your browser doesn't support javascript.
loading
The malignancy index is a robust predictor of prostate cancer.
Serafin, Antonio M; Chinhengo, Angela; Akudugu, John M.
Affiliation
  • Serafin AM; Division of Radiobiology, Department of Medical Imaging and Clinical Oncology, University of Stellenbosch, Tygerberg 7505, South Africa.
  • Chinhengo A; Corresponding Author.
  • Akudugu JM; Division of Radiobiology, Department of Medical Imaging and Clinical Oncology, University of Stellenbosch, Tygerberg 7505, South Africa.
Discov Med ; 29(158): 181-189, 2020.
Article in En | MEDLINE | ID: mdl-33007193
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Prostatic Neoplasms / Biomarkers, Tumor Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Discov Med Year: 2020 Document type: Article Affiliation country: Sudáfrica
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Prostatic Neoplasms / Biomarkers, Tumor Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Discov Med Year: 2020 Document type: Article Affiliation country: Sudáfrica